According to Beam Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.65912. At the end of 2023 the company had a P/S ratio of 5.87.
Year | P/S ratio | Change |
---|---|---|
2023 | 5.87 | -87.02% |
2022 | 45.2 | -56.8% |
2021 | 105 | -99.95% |
2020 | > 1000 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |